CHAMPOUX JENNIFER (Chief Operating Officer) sold 4.0% of their position (2.63K shares) of MONTE ROSA THERAPEUTICS, INC. on the open market
Open‑market sale worth $39.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/5/2026ACC: 0001193125-26-002401
Officer· Chief Operating Officer
Since May 2024
+190.37K
Net shares
Net buyer
$39.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
193K acquired · 2.63K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+35K
Price / share
—
Trade value
—
% of position
116.7%
1/2/2026
30K→65K
Common Stock
Direct
Shares
−2.63K
Price / share
$15.17
Trade value
$39.88K
% of position
4.0%
1/5/2026
65K→62.37K
Total
Net shares
+32.37K
Net value
-$39.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | A · Award | +35K | — | — | 116.7% | 30K | 65K |
| Common Stock Direct | 1/5/2026 | S · Sale | −2.63K | $15.17 | $39.88K | 4.0% | 65K | 62.37K |
| Total | +32.37K | -$39.88K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
158K shares
Shares
+158K
Strike price
15.31
Held after
158K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock158K shares | 1/2/2026 | A · Award | +158K | 15.31 | — | 158K |